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2. Life Cycle Assessment as a Tool for 
Assessing Environmental Sustainability 
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• Assessment of the potential environmental impact of a given 
product or service within the production chain and 
throughout its lifespan. 
 
– Goal and Scope Definition 
– Life Cycle Inventory (LCI) 
– Life Cycle Impact Assessment (LCIA) 
– Interpretation  
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A Major Challenge for Pharma: Data 
Management in LCI 
• Most time-consuming step 
• DATA MANAGEMENT to reduce cost of LCA 
• PLC  MES  SAP 
 
7 
Life Cycle Impact Assessment (LCIA): What 
should be our FOCUS? 
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Resources: How to quantify? 
• How to quantify all different kinds of resource? Energetic, physical 
resources?  
 Exergy Analysis (EA) & Exergetic Life Cycle Analysis (ELCA, e.g. CEENE 
Method) 
 
(Dewulf et al., Environ. Sci. Technol., 2008) 
Resources Exergyin 
Exergyout 
Product 
Exergetic 
efficiency 
ExergyProd 
Waste ExergyWaste 
Entropy 
prod. Exergyloss 
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JNJ-UGENT Research Portfolio: 
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Exemplary Case Study: Batch vs. Continuous Granulation 
Exergetic sustainability assessment 
of batch versus continuous wet 
granulation based pharmaceutical 
tablet manufacturing: a cohesive 
analysis at three different levels  
De Soete et al., 2013. Green Chemistry. 
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Methodological Advancements: Streamlined LCA 
1) Hotspot Analysis 
 
2) Product Group approach 
Product specific approach 
Life Cycle Based Resource Footprinting of Active Pharmaceutical (API) 
Synthesis Steps 
API # BPRs # BOs 
(A) Domperidone 10 492 
(B) Risperidone 7 502 
(C) Ketoconazole 8 733 
(D) Mitratapide 7 471 
(E) Levocabastine 8 641 
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Methodological Advancements: Streamlined LCA 
 
• Average value of cumulative resource consumption data 
• Backwards stepwise linear regression modeling: 
– 15 candidate predictor variables, selected based on: 
• Readily availability of data in business ERP systems 
• Expert knowledge 
 
– 4 predictor variable categories:  
• Process-oriented resource indicators (4) 
• Process operational variables (2) 
• Equipment variables (6) 
• Chemistry variables (3) 
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1) Hotspots identification 
 
 
De Soete et al., 2014, ES&T 
Subdivision of Chemicals 
OS: 67.2% 
BB: 22.5% 
Reagents: 10.2% 
Catalysts: 0.1% 
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2) Product group vs product specific 
 
 
De Soete et al., 2014, ES&T 
Selected Predictors: 
 
Organic Solvent use 
Molar Efficiency 
Δt 
ΔT 
# Reactors 
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4. Future Outlook 
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• Improved data acquisition systems from sensors, PLCs, 
etc. to central enterprise data systems (e.g. SAP, Infor LN) 
• Alignment of Pharmaceutical Sector through EU PEF 
Pharma Pilot 
• Focus on Human Health burden/benefit 
• Sustainable Supply Chain Management (SSCM) 
– It makes little sense to optimise in-house production without a 
proper procurement policy!!  Coupling organisation's ERP 
systems 
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